Gonca Erbaş

Gonca Erbaş

Auto-generated profile, based on publicly available information

Gonca Erbaş

Department of Radiology, Faculty of Medicine, Gazi University, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2020 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
HOHasan Ozger
Hasan Ozger
PYPınar Aysert Yildiz
Pınar Aysert Yildiz
ÜGÜmmügülsüm Gaygisiz
Ümmügülsüm Gaygisiz
ADASİYE UĞRAŞ DİKMEN
ASİYE UĞRAŞ DİKMEN
ZDZehra Demi̇rBaş
Zehra Demi̇rBaş
MDMurat Di̇zBay
Murat Di̇zBay
Pneumonia is the most serious clinical presentation of COVID-19. This study aimed to determine the demographic, clinical, and laboratory findings that can properly predict COVID-19 pneumonia. This study was conducted in the Gazi University hospital. All hospitalized patients with confirmed and suspected SARS-CoV-2 infection between 16 March 2020 and 30 April 2020 were analyzed retrospectively. COVID-19 patients were separated into two groups, pneumonia and nonpneumonia, and then compared to determine predicting factors for COVID-19 pneumonia. Variables that had a P-value of less than 0.20 and were not correlated with each other were included in the logistic regression model. Of the 247 patients included in the study 58% were female, and the median age was 40. COVID-19 was confirmed in 70.9% of these patients. Among the confirmed COVID-19 cases, 21.4% had pneumonia. In the multivariate analysis male sex (P = 0.028), hypertension (P = 0.022), and shortness of breath on hospital admission (P = 0.025) were significant factors predicting COVID-19 pneumonia. Shortness of breath, male sex, and hypertension were significant for predicting COVID-19 pneumonia on admission. Patients with these factors should be evaluated more carefully for diagnostic procedures, such as thorax CT.

7 March 2019 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
SKSeda Aladağ Kurt
Seda Aladağ Kurt
CYCem Yucel
Cem Yucel
SOSuna Özhan Oktar
Suna Özhan Oktar
GEGonca Erbaş
Gonca Erbaş
TSTevfi̇k Si̇nAn Sözen
Tevfi̇k Si̇nAn Sözen
AOAli Yusuf Oner
Ali Yusuf Oner
Background/aim: Evaluating the clinical efficacy of radiofrequency ablation (RFA) and cryotherapy, and scrutinising the therapeutic success of RENAL (radius, exophytic/endophytic, nearness to collecting system, anterior/posterior and location) nephrometry score in terms of possible complications and the predictive status of oncological results. Materials and Methods: Forty-five patients with biopsy-proven renal cell carcinomas (32 males, 13 females) treated with RFA and cryotherapy were included. Patients were 22-90 years old (average: 59.2 years). Statistical analyses were performed using SPSS for Windows. Results: A total of 79 lesions with dimensions varying between 0.9-4.5 cm (average: 2.2 cm) were ablated. Complete ablation was achieved in 72 (91.1%) lesions. Six repeat RFA sessions were applied to four (5%) lesions with residue/recurrence. The average RENAL nephrometry scores of lesions that underwent complete ablation and those that developed residue/recurrence were 6.3 and 7.7, respectively. The average recurrence-free survival time was 34.8 months (range: 3-55 months), while it was 44.6 months (range: 6-55 months) for cryotherapy and 28.6 months (range: 3-50 months) for RFA. Conclusions: Ablative therapies are minimally invasive and effective methods for treating small renal tumours. RENAL nephrometry scoring is a valuable system for standardizing renal tumours and evaluating the success of ablative therapies, possible complications, and oncological results.

9 June 2021 in International Journal Of Clinical Practice
Verified
Journal Article
Closed access
PDF file
NDNilgün Yılmaz Demirci
Nilgün Yılmaz Demirci
ADASİYE UĞRAŞ DİKMEN
ASİYE UĞRAŞ DİKMEN
CTCantürk Taşçı
Cantürk Taşçı
DDDeniz Doğan
Deniz Doğan
YAYakup Arslan
Yakup Arslan
AYAYDIN YILMAZ
AYDIN YILMAZ

6 September 2021 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
STSalih Topal
Salih Topal
EKEmrullah Kızıltunç
Emrullah Kızıltunç
BSBurak Sezenöz
Burak Sezenöz
MCMustafa Candemir,
Mustafa Candemir,
SÜserkan ünlü
serkan ünlü
AAAdnan Abacı
Adnan Abacı
Gamma-glutamyl transferase (GGT) to albumin ratio (GAR) has been shown to be helpful to diagnose and determine the severity of coronary artery disease (CAD). Coronary computed tomography angiography (CCTA) is a guide recommended non-invasive test that provides information about the presence, severity, and morphology of coronary plaques. In this study, our main aim was to investigate the relationship between the presence, morphology, and severity of coronary plaques detected via CCTA and GAR in patients with low to moderate risk for undiagnosed CAD. Nine hundred and sixty six patients were included who underwent CCTA. The severity of CAD and plaque morphology were investigated. CT-adapted Leaman score (CT-LeSc) was calculated to determine the extent of the CAD. The study population was further evaluated in three groups according to tertiles of GAR. Atherosclerotic plaques were more common in the male gender and older patients with conventional cardiovascular risk factors. GAR was significantly lower in patients with normal CCTA than in patients with a non-obstructive plaque or obstructive plaque on CCTA. Patients in upper GAR tertiles had a higher coronary calcium score (CACS) and CT-LeSc. GAR was one of the independent predictors to predict severe stenotic plaque and high CACS. GAR can independently predict the presence, extent, and severity of CAD determined by CT-LeSc. We believe as a cheap, safe, and widely available tool, GAR would be useful in the diagnosis of CAD.

28 March 2025 in Hamostaseologie
Verified
Journal Article
Closed access
PDF file
AMAyshan Mammadova
Ayshan Mammadova
KTKübra Taşkaraca
Kübra Taşkaraca
GJGünel Jeyranova
Günel Jeyranova
AOAysel Orujlu
Aysel Orujlu
MTMerve Tatlılıoğlu
Merve Tatlılıoğlu
IOI.Kivilcim Oguzulgen
I.Kivilcim Oguzulgen
High neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) are markers of subclinical inflammation and have been associated with prognosis and mortality in many diseases. In this study, we evaluated the comparative value of NLR and PLR in identifying high mortality risk in patients hospitalized with acute pulmonary thromboembolism (PTE), and their relationship with the anatomical burden of thrombus.Patients who were followed up due to PTE were evaluated retrospectively. NLR and PLR were calculated from complete blood counts. The thrombus burden was assessed by the Qanadli score; based on the patients' archival computed tomography angiography images. Mortality prediction was based on an algorithm using the Pulmonary Embolism Severity Index, echocardiographic findings, and troponin levels.Three hundred-two PTE patients were included in the study. Median NLR, PLR, and Qanadli score values were higher in nonsurvivors, with NLR (8.4 [2.2–18.9]) vs. (3.1 [0.4–13.1]), PLR (317 [87.6–525.3]) vs. (124.4 [30–476.3]), and Qanadli scores (21 [3–26]) vs. (9 [1–28]), respectively (p < 0.001). We showed that setting a threshold value of >4.45 for NLR and >151.59 for PLR significantly predicts the high mortality-risk group. In the receiver operating characteristic analysis, when the threshold value for the Qanadli score distinguishing between low-risk and high-risk disease was set at 15.5, the sensitivity was calculated as 98.8% and the specificity was 94.9% (p = 0.001).This study showed that NLR, PLR, and Qanadli scores can provide essential contributions to the clinician's determination of the anatomical burden of thrombus and disease severity in PTE patients.

30 September 2018 in The Journal of Infection in Developing Countries
Verified
Journal Article
Open access
PDF file
MPMehmet Sezgin Pepeler
Mehmet Sezgin Pepeler
ŞYŞeyma Yıldız
Şeyma Yıldız
ZYZeynep Arzu Yegin
Zeynep Arzu Yegin
ZÖZübeyde N Özkurt
Zübeyde N Özkurt
ÖTÖzlem G Tunçcan
Özlem G Tunçcan
ZYZeki Yildirim
Zeki Yildirim
Introduction: Invasive fungal infection (IFI) is a major cause of morbidity and mortality in allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients. A previous history of IFI is not an absolute contraindication for allo-HSCT, particularly in the era of secondary antifungal prophylaxis (SAP). Prompt diagnosis and therapy are essential for HSCT outcome. Methodology: The charts of 58 allo-HSCT recipients [median age:29.5 (16-62); M/F:41/17] who had a previous history of IFI were retrospectively reviewed. Results: Possible IFI was demonstrated in 32 (55.2%), probable in 13 (22.4%) and proven in 13 patients (22.4%). All patients received SAP [liposomal amphoterisin B (n ꞊ 35), voriconazole (n ꞊ 17), caspofungin (n ꞊ 2), posaconazole (n ꞊ 1), combination therapy (n = 3)] which was started on the first day of the conditioning regimen. Treatment success was better in the voriconazole group when compared to the amphotericin B arm (100% vs 69.2%; p = 0.029). Development of breakthrough IFI was more frequent in patients on amphotericin B prophylaxis (42.4% vs 23.1%; p = 0.036). Clinical and radiological response were achieved in 13 of 18 patients (72.2%) who developed breakthrough infection. Overall survival of the study population was 13.5% at a median follow-up of 154 (7-3285) days. Fungal mortality was found to be 23%. Overall survival was better in the voriconazole arm, without statistical significance (90% vs 65.8%, p > 0.05). Conclusions: Secondary antifungal prophylaxis is considered to be an indispensible strategy in patients with pre-HSCT IFI history. Voriconazole seems to be a relatively better alternative despite an underlying necessity of larger prospective trials.